Business Context and Reporting Period
Company: NanoViricides, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 5, 2014
Event: Item 8.01 Other Events – Exercise of Warrants
Key Financial Metrics
This filing reports a specific capital event rather than periodic financial performance. The filing text does not provide data on revenue, profit, cash flow, margins, debt, or liquidity.
- Warrants Exercised: 2,136,655 shares of common stock
- Exercise Price: $3.50 per share
- Aggregate Proceeds: $7,478,292.50
Material Changes and Context
The proceeds resulted from the exercise of "Registered Warrants" previously issued in private placement offerings between 2005 and September 2009. These warrants were registered under a Form S-3 filed on July 17, 2014, and declared effective by the SEC on August 1, 2014. The filing notes that any Registered Warrants not exercised by August 15, 2014, have expired.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, outlook, or specific risk factors beyond the expiration of unexercised warrants.
Investor Verification Checklist
- Verify the total number of shares outstanding post-exercise to assess dilution impact.
- Confirm the company's cash position following the receipt of approximately $7.48 million in proceeds.
- Review the status of the Form S-3 registration to ensure all registered warrants were accounted for prior to the August 15, 2014 expiration date.